Related references
Note: Only part of the references are listed.Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX
Kazuma Nakashima et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Development of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX
Shimpei Iikuni et al.
MOLECULAR PHARMACEUTICS (2019)
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi et al.
CELL DEATH & DISEASE (2019)
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
Sven De Bruycker et al.
EJNMMI RESEARCH (2019)
Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing
Adam Cepa et al.
APPLIED RADIATION AND ISOTOPES (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies
Mark W. Dewhirst et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Acetazolamide-based [F-18]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors
Kunal N. More et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
Srishti Singh et al.
MOLECULES (2018)
Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
Shimpei Iikuni et al.
THERANOSTICS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis
Alexander Greenhough et al.
EMBO MOLECULAR MEDICINE (2018)
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
Kaitlin Graham et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging
Zhengxing Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
Joseph Lau et al.
THERANOSTICS (2017)
Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment
Ayelet David
ADVANCED DRUG DELIVERY REVIEWS (2017)
Molecular mechanisms of hypoxia in cancer
Amarnath Challapalli et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Jia-nan Liu et al.
CHEMICAL REVIEWS (2017)
Renal cell cancer histological subtype distribution differs by race and sex
Loren Lipworth et al.
BJU INTERNATIONAL (2016)
64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2
Fan Li et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging
Mark W. Dewhirst et al.
CANCER RESEARCH (2016)
A 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo
Nikolaus Krall et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with 68Ga-Labeled Benzenesulfonamides
Joseph Lau et al.
MOLECULAR PHARMACEUTICS (2016)
Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas
Pia Viikila et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Il Minn et al.
ONCOTARGET (2016)
Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
Brian Shuch et al.
EUROPEAN UROLOGY (2015)
Ultrasensitive Near-Infrared Fluorescence-Enhanced Probe for in Vivo Nitroreductase Imaging
Yuhao Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Targeting Carbonic Anhydrase IX Activity and Expression
Brian P. Mahon et al.
MOLECULES (2015)
Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation
Moreno Wichert et al.
NATURE CHEMISTRY (2015)
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
Jaromir Pastorek et al.
SEMINARS IN CANCER BIOLOGY (2015)
Optimizing Hypoxia Detection and Treatment Strategies
Cameron J. Koch et al.
SEMINARS IN NUCLEAR MEDICINE (2015)
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Xing Yang et al.
ONCOTARGET (2015)
Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo
Siao-Syun Guan et al.
ONCOTARGET (2015)
The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
Joseph C. Walsh et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
S. R. McKeown
BRITISH JOURNAL OF RADIOLOGY (2014)
Fusion protein linkers: Property, design and functionality
Xiaoying Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: A new concept of dual targeting drugs
Ludwig Dubois et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
Jose J. G. Marin et al.
DRUG METABOLISM REVIEWS (2012)
Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010
Martin Pichler et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX
Shoaib Rana et al.
PLOS ONE (2012)
Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
Alexander B. Stillebroer et al.
EUROPEAN UROLOGY (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts
Sean Carlin et al.
PLOS ONE (2010)
A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology
Vasileios Askoxylakis et al.
PLOS ONE (2010)
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Michael M. Schmidt et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects
Nathan E. Basken et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
PET and SPECT imaging of tumor biology: New approaches towards oncology drug discovery and development
Marcian E. Van Dort et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2008)
The role of carbonic anhydrases in renal physiology
J. M. Purkerson et al.
KIDNEY INTERNATIONAL (2007)
Prevention of acute mountain sickness by acetazolamide in Nepali porters: A double-blind controlled trial
Peter Hillenbrand et al.
WILDERNESS & ENVIRONMENTAL MEDICINE (2006)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Share Paper
